Incremental, symptom-limited CPET is safe in patients with suspected or confirmed pulmonary hypertension. In over 3800 tests, no deaths or syncopal events occurred, with an adverse event rate of only 0.05%, supporting wider use under proper supervision.
Lung Sask in collaboration with RESPTREC® offers the Professional Education Portal as a method for respiratory educators and health care providers to enhance their professional learning with continuing education opportunities.
Over 6000+ more articles available in the Professional Education Portal.
Read articles and watch video presentations on the most recent research, position papers and guidelines. Track your CE time with the provided logbook.